MoneyWorks4Me

Amrutanjan Healthcar - Quaterly Results

04 Nov 2022 Evaluate
The quarter ended September 2022 witnessed marginal change in the total revenue. The figure for the mentioned quarter is pegged at Rs. 1107.19 millions.A big decline of -35.69% was reported for the quarter ended September 2022 to Rs. 127.64  millions from Rs. 198.47 millions of corresponding previous quarter.A decline of 189.61 millions was observed in the OP in the quarter ended September 2022 from 272.29 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202209 202109 % Var 202209 202109 % Var 202203 202103 % Var
Sales 1107.19 1103.82 0.31 1816.73 1885.94 -3.67 4058.42 3328.44 21.93
Other Income 30.32 42.85 -29.24 60.44 70.24 -13.95 153.83 113.20 35.89
PBIDT 189.61 272.29 -30.36 253.03 445.20 -43.16 948.56 860.73 10.20
Interest 0.20 0.69 -71.01 0.44 1.54 -71.43 4.85 5.00 -3.00
PBDT 189.41 271.60 -30.26 252.59 443.66 -43.07 943.71 855.73 10.28
Depreciation 15.21 8.05 88.94 25.88 17.25 50.03 37.95 36.70 3.41
PBT 174.20 263.55 -33.90 226.71 426.41 -46.83 905.76 819.03 10.59
TAX 46.56 65.08 -28.46 62.43 107.37 -41.86 233.88 207.14 12.91
Deferred Tax 0.00 0.00 0.00 -1.74 0.00 0.00 0.00 0.00 0.00
PAT 127.64 198.47 -35.69 164.28 319.04 -48.51 671.88 611.89 9.80
Equity 29.23 29.23 0.00 29.23 29.23 0.00 29.23 29.23 0.00
PBIDTM(%) 17.13 24.67 -30.58 13.93 23.61 -41.00 23.37 25.86 -9.62
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..